PIDS(@PIDSociety) 's Twitter Profileg
PIDS

@PIDSociety

Pediatric Infectious Diseases Society - Promoting excellence in the diagnosis, management and prevention of pediatric infectious diseases

ID:392972400

linkhttp://www.pids.org calendar_today17-10-2011 20:49:23

7,2K Tweets

5,7K Followers

445 Following

Follow People
IDWeek(@IDWeekmtg) 's Twitter Profile Photo

⌛ Time is running out! Submissions for abstracts are due TOMORROW, Tuesday, May 7 at 11:59pm ET!

Submit your abstract: idweek.org/call-for-abstr…

⌛ Time is running out! Submissions for #IDWeek2024 abstracts are due TOMORROW, Tuesday, May 7 at 11:59pm ET! Submit your abstract: idweek.org/call-for-abstr…
account_circle
PIDS(@PIDSociety) 's Twitter Profile Photo

Final PIDS session of PAS features Drs. Mark Scleiss and Mary Caserta on Should We Be Adding CMV to the Universal Newborn Screening Panel? Advocacy, Policy, Progress, and Controversy

Final PIDS session of PAS features Drs. Mark Scleiss and Mary Caserta on Should We Be Adding CMV to the Universal Newborn Screening Panel? Advocacy, Policy, Progress, and Controversy #PAS2024
account_circle
PIDS(@PIDSociety) 's Twitter Profile Photo

Feeling inspired by our posts of the research being share during PAS? Submit your abstract (abstractscorecard.com/cfp/submit/log…) or case (abstractscorecard.com/cfp/submit/log…) for consideration at IDWeek. The deadline is tomorrow (Tuesday, May 7) by 11:59pm ET.

account_circle
PIDS(@PIDSociety) 's Twitter Profile Photo

Dr. Delma Nieves presenting her Safety and tolerability of Remdesivir for severe infection and prevention of progression of disease in pediatric patients with SARS-CoV-2 infection as part of Pediatric Therapeutics and Pharmacology session.

Dr. Delma Nieves presenting her Safety and tolerability of Remdesivir for severe infection and prevention of progression of disease in pediatric patients with SARS-CoV-2 infection as part of Pediatric Therapeutics and Pharmacology session. #PAS2024
account_circle
PIDS(@PIDSociety) 's Twitter Profile Photo

PIDS members Dr. Joseph St. Geme (3rd from left) and Dr. William C. Golden (5th from left) participated in the panel discussion of Pediatric Subspecialty Workforce 2024: State, Needs, Barriers, and Solutions.

PIDS members Dr. Joseph St. Geme (3rd from left) and Dr. William C. Golden (5th from left) participated in the panel discussion of Pediatric Subspecialty Workforce 2024: State, Needs, Barriers, and Solutions. #PAS2024
account_circle
PIDS(@PIDSociety) 's Twitter Profile Photo

Dr. Buddy Creech presents the maternal vaccine side of RSV as Maternal Vaccination for Infant Protection from RSV

Dr. Buddy Creech presents the maternal vaccine side of RSV as Maternal Vaccination for Infant Protection from RSV #PAS2024
account_circle
PIDS(@PIDSociety) 's Twitter Profile Photo

In room 206 BD starting at 2pm, Optimal Strategy for RSV Protection in Infancy: Maternal Vaccine or Newborn Monoclonal Antibody, which features PIDS members Dr. Buddy Creech and Dr. Karen Puopolo.

In room 206 BD starting at 2pm, Optimal Strategy for RSV Protection in Infancy: Maternal Vaccine or Newborn Monoclonal Antibody, which features PIDS members Dr. Buddy Creech and Dr. Karen Puopolo. #PAS2024
account_circle
PIDS(@PIDSociety) 's Twitter Profile Photo

Live from the Trainee Zone: Dr. Bill Steinbach presenting How to Get a Job - Practical Advice and Insight

Live from the #PAS2024 Trainee Zone: Dr. Bill Steinbach presenting How to Get a Job - Practical Advice and Insight
account_circle
PIDS(@PIDSociety) 's Twitter Profile Photo

From the PharmD card of the pediatric lung infections controversies session: Shane Cross delivers the pro side of Inhaled antibiotics for treatment of children with complicated lung infections

From the PharmD card of the pediatric lung infections controversies session: Shane Cross delivers the pro side of Inhaled antibiotics for treatment of children with complicated lung infections #PAS2024
account_circle